Crossmark Global Holdings Inc. reduced its position in shares of Genpact Limited (NYSE:G - Free Report) by 1.6% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 389,739 shares of the business services provider's stock after selling 6,525 shares during the quarter. Crossmark Global Holdings Inc. owned about 0.22% of Genpact worth $19,635,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in G. Callan Capital LLC boosted its stake in shares of Genpact by 2.9% during the 1st quarter. Callan Capital LLC now owns 12,312 shares of the business services provider's stock worth $620,000 after acquiring an additional 351 shares in the last quarter. Envestnet Asset Management Inc. boosted its stake in shares of Genpact by 124.2% during the 1st quarter. Envestnet Asset Management Inc. now owns 412,343 shares of the business services provider's stock worth $20,774,000 after acquiring an additional 228,391 shares in the last quarter. Penserra Capital Management LLC boosted its position in shares of Genpact by 6.8% in the first quarter. Penserra Capital Management LLC now owns 15,310 shares of the business services provider's stock worth $771,000 after buying an additional 979 shares during the period. World Investment Advisors acquired a new stake in shares of Genpact in the first quarter worth $448,000. Finally, Timber Creek Capital Management LLC boosted its position in shares of Genpact by 27.1% in the first quarter. Timber Creek Capital Management LLC now owns 98,856 shares of the business services provider's stock worth $4,980,000 after buying an additional 21,094 shares during the period. 96.03% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other news, Director Nicholas C. Gangestad bought 2,000 shares of the stock in a transaction on Tuesday, May 13th. The shares were purchased at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the purchase, the director directly owned 2,000 shares in the company, valued at $87,940. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 3.07% of the company's stock.
Genpact Price Performance
NYSE:G traded down $0.44 during trading hours on Wednesday, hitting $45.69. The company's stock had a trading volume of 985,341 shares, compared to its average volume of 1,416,168. The stock has a fifty day simple moving average of $44.12 and a 200-day simple moving average of $47.00. The company has a market capitalization of $7.99 billion, a P/E ratio of 15.59, a PEG ratio of 2.01 and a beta of 0.94. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.45 and a quick ratio of 2.45. Genpact Limited has a twelve month low of $30.38 and a twelve month high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. The company had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Genpact had a return on equity of 22.35% and a net margin of 10.88%. The firm's revenue was up 7.4% compared to the same quarter last year. During the same period last year, the company earned $0.73 earnings per share. On average, analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.
Genpact Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Wednesday, June 18th were given a $0.17 dividend. The ex-dividend date of this dividend was Wednesday, June 18th. This represents a $0.68 annualized dividend and a yield of 1.49%. Genpact's dividend payout ratio is currently 23.21%.
Analyst Upgrades and Downgrades
Several analysts recently commented on G shares. Needham & Company LLC restated a "buy" rating and set a $50.00 price target on shares of Genpact in a report on Monday, June 30th. Wall Street Zen upgraded shares of Genpact from a "buy" rating to a "strong-buy" rating in a research note on Friday, June 6th. Mizuho lifted their target price on shares of Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research note on Tuesday, July 1st. Finally, Robert W. Baird decreased their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $50.14.
Read Our Latest Analysis on Genpact
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Recommended Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.